ADVERTISEMENT

Solara Active Pharma - Working On Multiple Fronts To Enhance Business Prospects: Motilal Oswal

Solara Active Pharma - Working On Multiple Fronts To Enhance Business Prospects: Motilal Oswal

Solara Active Pharma Science R&D Facility. (image: Company website)
Solara Active Pharma Science R&D Facility. (image: Company website)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Motilal Oswal Report

We recently met with the management of Solara Active Pharma Science Ltd. to understand the business outlook in further detail. Here are the key takeaways:

  • backward integration in Ibuprofen manufacturing and the easing of supply-side pressure have come in handy for Solara Active Pharma, given the current situation of subdued demand for the product.

  • the company is progressing well on building a niche product pipeline and broadening its presence in the regulated and rest of world markets.

We remain positive on Solara Active Pharma on the back of-

  • portfolio expansion, with a good mix of limited-competition products,

  • increasing reach, and

  • further capability building in the contract research and manufacturing services segment.

Also, the recent correction provides adequate comfort on valuations.

Click on the attachment to read the full report:

Motilal Oswal Solara Active Pharma Company Update.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.